This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Lieber Institute, Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Innovations in Neurological Treatment by Inventor Brady Maher
Introduction
Brady Maher is a pioneering inventor based in Baltimore, MD (US), known for her significant contributions to the field of neurology. With a focus on treating neurological and neurodevelopmental diseases, she has developed innovative methods that address critical health challenges.
Latest Patents
Brady Maher holds a patent for the treatment of neurological and neurodevelopmental diseases and disorders associated with aberrant ion channel expression and activity. This patent outlines methods for treating conditions characterized by ectopic expression of specific ion channels, particularly the Nav1.8 subtype SCN10a sodium channel and the KCNQ1 potassium channel. By administering antagonists of these ion channels, her methods aim to block or reduce aberrant activity in neuronal cells of the central nervous system (CNS). This approach has the potential to normalize behavioral and cognitive defects associated with various disorders, including Pitt-Hopkins Syndrome, autism, and schizophrenia.
Career Highlights
Brady Maher is affiliated with the Lieber Institute, Inc., where she continues to advance her research and innovations in the field of neurology. Her work is characterized by a commitment to improving the lives of individuals affected by complex neurological conditions.
Collaborations
[Section skipped due to space constraints.]
Conclusion
Brady Maher's innovative approaches to treating neurological disorders highlight her dedication to advancing medical science and improving patient outcomes. Her contributions are paving the way for new therapeutic strategies in neurology.